MyAllergy 295+ Advanced allergy mapping for complete relief.

The Next Generation in Allergy Diagnostics

MyAllergy 295+ is an advanced

solid-phase immunoassay using

nano-particle-coupled allergen extracts and molecular allergens arranged on a microarray.

It includes:

• 295 allergens, including

178 molecular components

• Broader diagnostic capability for complex or cross-reactive allergies
• Enhanced precision for personalized treatment plans

This state-of-the-art test allows clinicians to offer evidence-based, targeted therapy by identifying both primary and cross-reactive sensitizations.